Kang, H. W., Lee, H. Y., Byun, Y. J., Jeong, P., Yoon, J. S., Kim, D. H., . . . Kim, W. (2020). A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone. Investig Clin Urol.
Citação norma ChicagoKang, Ho Won, et al. "A Novel Urinary MRNA Signature Using the Droplet Digital Polymerase Chain Reaction Platform Improves Discrimination between Prostate Cancer and Benign Prostatic Hyperplasia Within the Prostate-specific Antigen Gray Zone." Investig Clin Urol 2020.
Citação norma MLAKang, Ho Won, et al. "A Novel Urinary MRNA Signature Using the Droplet Digital Polymerase Chain Reaction Platform Improves Discrimination between Prostate Cancer and Benign Prostatic Hyperplasia Within the Prostate-specific Antigen Gray Zone." Investig Clin Urol 2020.